{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T00:44:03Z","timestamp":1794185043391,"version":"4.8.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Science and ICT of Korea","award":["2016M3A9B6902061"],"award-info":[{"award-number":["2016M3A9B6902061"]}]},{"name":"Ministry of Science and ICT of Korea","award":["2018M3A9F3020970"],"award-info":[{"award-number":["2018M3A9F3020970"]}]},{"name":"SNUH research fund","award":["03-2019-0180"],"award-info":[{"award-number":["03-2019-0180"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Early identification of patients at risk of developing preeclampsia (PE) would allow providers to tailor their prenatal management and adopt preventive strategies, such as low-dose aspirin. Nevertheless, no mid-trimester biomarkers have as yet been proven useful for prediction of PE. This study investigates the ability of metabolomic biomarkers in mid-trimester maternal plasma to predict PE. A case\u2013control study was conducted including 33 pregnant women with mid-trimester maternal plasma (gestational age [GA], 16\u201324\u00a0weeks) who subsequently developed PE and 66 GA-matched controls with normal outcomes (mid-trimester cohort). Plasma samples were comprehensively profiled for primary metabolic and lipidomic signatures based on gas chromatography time-of-flight mass spectrometry (GC-TOF MS) and liquid chromatography Orbitrap mass spectrometry (LC-Orbitrap MS). A potential biomarker panel was computed based on binary logistic regression and evaluated using receiver operating characteristic (ROC) analysis. To evaluate whether this panel can be also used in late pregnancy, a retrospective cohort study was conducted using plasma collected from women who delivered in the late preterm period because of PE (n\u2009=\u200913) or other causes (n\u2009=\u200921) (at-delivery cohort). Metabolomic biomarkers were compared according to the indication for delivery. Performance of the metabolomic panel to identify patients with PE was compared also to a commonly used standard, the plasma soluble fms-like tyrosine kinase-1\/placental growth factor (sFlt-1\/PlGF) ratio. In the mid-trimester cohort, a total of 329 metabolites were identified and semi-quantified in maternal plasma using GC-TOF MS and LC-Orbitrap-MS. Binary logistic regression analysis proposed a mid-trimester biomarker panel for the prediction of PE with five metabolites (SM C28:1, SM C30:1, LysoPC C19:0, LysoPE C20:0, propane-1,3-diol). This metabolomic model predicted PE better than PlGF (AUC [95% CI]: 0.868 [0.844\u20130.891] vs 0.604 [0.485\u20130.723]) and sFlt-1\/PlGF ratio. Analysis of plasma from the at-delivery cohort confirmed the ability of this biomarker panel to distinguish PE from non-PE, with comparable discrimination power to that of the sFlt-1\/PlGF ratio. In conclusion, an integrative metabolomic biomarker panel in mid-trimester maternal plasma can accurately predict the development of PE and showed good discriminatory power in patients with PE at delivery.<\/jats:p>","DOI":"10.1038\/s41598-020-72852-4","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T10:03:01Z","timestamp":1601460181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia"],"prefix":"10.1038","volume":"10","author":[{"given":"Seung Mi","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Mi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Mi","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subeen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol R.","family":"Norwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Yup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joong Shin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"72852_CR1","doi-asserted-by":"publisher","unstructured":"1American College of, O., Gynecologists & Task Force on Hypertension in, P. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol122, 1122\u20131131, https:\/\/doi.org\/10.1097\/01.AOG.0000437382.03963.88 (2013).","DOI":"10.1097\/01.AOG.0000437382.03963.88"},{"key":"72852_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","volume":"367","author":"KS Khan","year":"2006","unstructured":"Khan, K. S., Wojdyla, D., Say, L., Gulmezoglu, A. M. & Van Look, P. F. WHO analysis of causes of maternal death: a systematic review. Lancet 367, 1066\u20131074. https:\/\/doi.org\/10.1016\/S0140-6736(06)68397-9 (2006).","journal-title":"Lancet"},{"key":"72852_CR3","doi-asserted-by":"publisher","unstructured":"3Capriglione, S. et al. Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literature. J. Mater. Fetal Neonatal. Med., 1\u201310, https:\/\/doi.org\/10.1080\/14767058.2018.1495191 (2018).","DOI":"10.1080\/14767058.2018.1495191"},{"key":"72852_CR4","first-page":"56","volume":"13","author":"AF Sunjaya","year":"2019","unstructured":"Sunjaya, A. F. & Sunjaya, A. P. Evaluation of serum biomarkers and other diagnostic modalities for early diagnosis of preeclampsia. J. Family Reprod. Health 13, 56\u201369 (2019).","journal-title":"J. Family Reprod. Health"},{"key":"72852_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.preghy.2018.03.010","volume":"14","author":"FP McCarthy","year":"2018","unstructured":"McCarthy, F. P., Ryan, R. M. & Chappell, L. C. Prospective biomarkers in preterm preeclampsia: a review. Pregnancy Hypertens. 14, 72\u201378. https:\/\/doi.org\/10.1016\/j.preghy.2018.03.010 (2018).","journal-title":"Pregnancy Hypertens."},{"key":"72852_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12884-015-0608-y","volume":"15","author":"Y Zhong","year":"2015","unstructured":"Zhong, Y., Zhu, F. & Ding, Y. Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis. BMC Pregnancy Childbirth 15, 191. https:\/\/doi.org\/10.1186\/s12884-015-0608-y (2015).","journal-title":"BMC Pregnancy Childbirth"},{"key":"72852_CR7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/14737159.2018.1546579","volume":"18","author":"B Huppertz","year":"2018","unstructured":"Huppertz, B. An updated view on the origin and use of angiogenic biomarkers for preeclampsia. Expert Rev. Mol. Diagn. 18, 1053\u20131061. https:\/\/doi.org\/10.1080\/14737159.2018.1546579 (2018).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"72852_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.prostaglandins.2018.09.006","volume":"139","author":"D Wojcik-Baszko","year":"2018","unstructured":"Wojcik-Baszko, D., Charkiewicz, K. & Laudanski, P. Role of dyslipidemia in preeclampsia-a review of lipidomic analysis of blood, placenta, syncytiotrophoblast microvesicles and umbilical cord artery from women with preeclampsia. Prostaglandins Other Lipid Mediat. 139, 19\u201323. https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.09.006 (2018).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"72852_CR9","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/jcp.27291","volume":"234","author":"Y Lv","year":"2019","unstructured":"Lv, Y. et al. Roles of microRNAs in preeclampsia. J. Cell. Physiol. 234, 1052\u20131061. https:\/\/doi.org\/10.1002\/jcp.27291 (2019).","journal-title":"J. Cell. Physiol."},{"key":"72852_CR10","doi-asserted-by":"publisher","first-page":"e13055","DOI":"10.1111\/aji.13055","volume":"80","author":"I Bellos","year":"2018","unstructured":"Bellos, I., Karageorgiou, V., Kapnias, D., Karamanli, K. E. & Siristatidis, C. The role of interleukins in preeclampsia: a comprehensive review. Am. J. Reprod. Immunol. 80, e13055. https:\/\/doi.org\/10.1111\/aji.13055 (2018).","journal-title":"Am. J. Reprod. Immunol."},{"key":"72852_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/AOG.0000000000001508","volume":"128","author":"S Duckworth","year":"2016","unstructured":"Duckworth, S. et al. Diagnostic biomarkers in women with suspected preeclampsia in a prospective multicenter study. Obstet. Gynecol. 128, 245\u2013252. https:\/\/doi.org\/10.1097\/AOG.0000000000001508 (2016).","journal-title":"Obstet. Gynecol."},{"key":"72852_CR12","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/1471-0528.12128","volume":"120","author":"L Myatt","year":"2013","unstructured":"Myatt, L. et al. Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?. BJOG 120, 1183\u20131191. https:\/\/doi.org\/10.1111\/1471-0528.12128 (2013).","journal-title":"BJOG"},{"key":"72852_CR13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1586\/14737159.8.5.617","volume":"8","author":"GA Gowda","year":"2008","unstructured":"Gowda, G. A. et al. Metabolomics-based methods for early disease diagnostics. Expert Rev. Mol. Diagn. 8, 617\u2013633. https:\/\/doi.org\/10.1586\/14737159.8.5.617 (2008).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"72852_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/msb4100095","volume":"2","author":"JK Nicholson","year":"2006","unstructured":"Nicholson, J. K. Global systems biology, personalized medicine and molecular epidemiology. Mol. Syst. Biol. 2, 52. https:\/\/doi.org\/10.1038\/msb4100095 (2006).","journal-title":"Mol. Syst. Biol."},{"key":"72852_CR15","doi-asserted-by":"publisher","first-page":"15169","DOI":"10.1038\/s41598-019-51285-8","volume":"9","author":"SM Lee","year":"2019","unstructured":"Lee, S. M. et al. Metabolic biomarkers in midtrimester maternal plasma can accurately predict adverse pregnancy outcome in patients with SLE. Sci. Rep. 9, 15169. https:\/\/doi.org\/10.1038\/s41598-019-51285-8 (2019).","journal-title":"Sci. Rep."},{"key":"72852_CR16","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/19396368.2018.1482968","volume":"64","author":"MGBF Nobakht","year":"2018","unstructured":"Nobakht, M. G. B. F. Application of metabolomics to preeclampsia diagnosis. Syst. Biol. Reprod. Med. 64, 324\u2013339. https:\/\/doi.org\/10.1080\/19396368.2018.1482968 (2018).","journal-title":"Syst. Biol. Reprod. Med."},{"key":"72852_CR17","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41598-018-37757-3","volume":"9","author":"SM Lee","year":"2019","unstructured":"Lee, S. M. et al. Increased biosynthesis and accumulation of cholesterol in maternal plasma, but not amniotic fluid in pre-eclampsia. Sci. Rep. 9, 1550. https:\/\/doi.org\/10.1038\/s41598-018-37757-3 (2019).","journal-title":"Sci. Rep."},{"key":"72852_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/1933719108316908","volume":"15","author":"LC Kenny","year":"2008","unstructured":"Kenny, L. C. et al. Detection and identification of novel metabolomic biomarkers in preeclampsia. Reprod. Sci. 15, 591\u2013597. https:\/\/doi.org\/10.1177\/1933719108316908 (2008).","journal-title":"Reprod. Sci."},{"key":"72852_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.preghy.2013.11.005","volume":"4","author":"R Mukherjee","year":"2014","unstructured":"Mukherjee, R., Ray, C. D., Ray, S., Dasgupta, S. & Chaudhury, K. Altered metabolic profile in early and late onset preeclampsia: an FTIR spectroscopic study. Pregnancy Hypertens. 4, 70\u201380. https:\/\/doi.org\/10.1016\/j.preghy.2013.11.005 (2014).","journal-title":"Pregnancy Hypertens."},{"key":"72852_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bbrc.2017.02.032","volume":"485","author":"T Chen","year":"2017","unstructured":"Chen, T., He, P., Tan, Y. & Xu, D. Biomarker identification and pathway analysis of preeclampsia based on serum metabolomics. Biochem. Biophys. Res. Commun. 485, 119\u2013125. https:\/\/doi.org\/10.1016\/j.bbrc.2017.02.032 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"72852_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s10517-013-2225-y","volume":"155","author":"NV Senyavina","year":"2013","unstructured":"Senyavina, N. V., Khaustova, S. A., Grebennik, T. K. & Pavlovich, S. V. Analysis of purine metabolites in maternal serum for evaluating the risk of gestosis. Bull. Exp. Biol. Med. 155, 682\u2013684. https:\/\/doi.org\/10.1007\/s10517-013-2225-y (2013).","journal-title":"Bull. Exp. Biol. Med."},{"key":"72852_CR22","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3109\/14767058.2012.680254","volume":"25","author":"RO Bahado-Singh","year":"2012","unstructured":"Bahado-Singh, R. O. et al. Metabolomics and first-trimester prediction of early-onset preeclampsia. J. Mater. Fetal Neonatal. Med. 25, 1840\u20131847. https:\/\/doi.org\/10.3109\/14767058.2012.680254 (2012).","journal-title":"J. Mater. Fetal Neonatal. Med."},{"key":"72852_CR23","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1161\/HYPERTENSIONAHA.110.157297","volume":"56","author":"LC Kenny","year":"2010","unstructured":"Kenny, L. C. et al. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension 56, 741\u2013749. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.157297 (2010).","journal-title":"Hypertension"},{"issue":"58","key":"72852_CR24","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ajog.2012.11.003","volume":"208","author":"RO Bahado-Singh","year":"2013","unstructured":"Bahado-Singh, R. O. et al. First-trimester metabolomic detection of late-onset preeclampsia. Am. J. Obstet. Gynecol. 208(58), e51-57. https:\/\/doi.org\/10.1016\/j.ajog.2012.11.003 (2013).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"72852_CR25","doi-asserted-by":"publisher","unstructured":"25Bahado-Singh, R. O. et al. Validation of metabolomic models for prediction of early-onset preeclampsia. Am. J. Obstet. Gynecol.213, 530 e531\u2013530 e510, https:\/\/doi.org\/10.1016\/j.ajog.2015.06.044 (2015).","DOI":"10.1016\/j.ajog.2015.06.044"},{"key":"72852_CR26","doi-asserted-by":"publisher","first-page":"857108","DOI":"10.1155\/2015\/857108","volume":"2015","author":"MP Koster","year":"2015","unstructured":"Koster, M. P. et al. First-trimester serum acylcarnitine levels to predict preeclampsia: a metabolomics approach. Dis. Mark. 2015, 857108. https:\/\/doi.org\/10.1155\/2015\/857108 (2015).","journal-title":"Dis. Mark."},{"key":"72852_CR27","doi-asserted-by":"publisher","first-page":"e98540","DOI":"10.1371\/journal.pone.0098540","volume":"9","author":"S Kuc","year":"2014","unstructured":"Kuc, S. et al. Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia. PLoS ONE 9, e98540. https:\/\/doi.org\/10.1371\/journal.pone.0098540 (2014).","journal-title":"PLoS ONE"},{"key":"72852_CR28","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/pd.2822","volume":"31","author":"AO Odibo","year":"2011","unstructured":"Odibo, A. O. et al. First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study. Prenat. Diagn. 31, 990\u2013994. https:\/\/doi.org\/10.1002\/pd.2822 (2011).","journal-title":"Prenat. Diagn."},{"key":"72852_CR29","doi-asserted-by":"publisher","first-page":"21520","DOI":"10.3390\/ijms160921520","volume":"16","author":"M Austdal","year":"2015","unstructured":"Austdal, M. et al. First trimester urine and serum metabolomics for prediction of preeclampsia and gestational hypertension: a prospective screening study. Int. J. Mol. Sci. 16, 21520\u201321538. https:\/\/doi.org\/10.3390\/ijms160921520 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"72852_CR30","doi-asserted-by":"publisher","first-page":"e91923","DOI":"10.1371\/journal.pone.0091923","volume":"9","author":"M Austdal","year":"2014","unstructured":"Austdal, M. et al. Metabolomic biomarkers in serum and urine in women with preeclampsia. PLoS ONE 9, e91923. https:\/\/doi.org\/10.1371\/journal.pone.0091923 (2014).","journal-title":"PLoS ONE"},{"key":"72852_CR31","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1021\/pr4002355","volume":"12","author":"SO Diaz","year":"2013","unstructured":"Diaz, S. O. et al. Second trimester maternal urine for the diagnosis of trisomy 21 and prediction of poor pregnancy outcomes. J. Proteome Res. 12, 2946\u20132957. https:\/\/doi.org\/10.1021\/pr4002355 (2013).","journal-title":"J. Proteome Res."},{"key":"72852_CR32","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.placenta.2015.10.019","volume":"36","author":"M Austdal","year":"2015","unstructured":"Austdal, M. et al. Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics. Placenta 36, 1455\u20131462. https:\/\/doi.org\/10.1016\/j.placenta.2015.10.019 (2015).","journal-title":"Placenta"},{"key":"72852_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.yexcr.2017.07.029","volume":"359","author":"X Zhou","year":"2017","unstructured":"Zhou, X. et al. Impaired mitochondrial fusion, autophagy, biogenesis and dysregulated lipid metabolism is associated with preeclampsia. Exp. Cell Res. 359, 195\u2013204. https:\/\/doi.org\/10.1016\/j.yexcr.2017.07.029 (2017).","journal-title":"Exp. Cell Res."},{"key":"72852_CR34","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.2741\/1470","volume":"9","author":"S Jain","year":"2004","unstructured":"Jain, S., Jayasimhulu, K. & Clark, J. F. Metabolomic analysis of molecular species of phospholipids from normotensive and preeclamptic human placenta electrospray ionization mass spectrometry. Front. Biosci. 9, 3167\u20133175. https:\/\/doi.org\/10.2741\/1470 (2004).","journal-title":"Front. Biosci."},{"key":"72852_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev-physiol-020518-114444","volume":"81","author":"B Wang","year":"2019","unstructured":"Wang, B. & Tontonoz, P. Phospholipid remodeling in physiology and disease. Annu. Rev. Physiol. 81, 165\u2013188. https:\/\/doi.org\/10.1146\/annurev-physiol-020518-114444 (2019).","journal-title":"Annu. Rev. Physiol."},{"issue":"Suppl A","key":"72852_CR36","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.placenta.2008.11.009","volume":"30","author":"JM Roberts","year":"2009","unstructured":"Roberts, J. M. & Hubel, C. A. The two stage model of preeclampsia: variations on the theme. Placenta 30(Suppl A), S32-37. https:\/\/doi.org\/10.1016\/j.placenta.2008.11.009 (2009).","journal-title":"Placenta"},{"key":"72852_CR37","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/ajcn\/nqy051","volume":"107","author":"Y Zhu","year":"2018","unstructured":"Zhu, Y. et al. A prospective and longitudinal study of plasma phospholipid saturated fatty acid profile in relation to cardiometabolic biomarkers and the risk of gestational diabetes. Am. J. Clin. Nutr. 107, 1017\u20131026. https:\/\/doi.org\/10.1093\/ajcn\/nqy051 (2018).","journal-title":"Am. J. Clin. Nutr."},{"key":"72852_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/ijo.2011.157","volume":"36","author":"BT Steffen","year":"2012","unstructured":"Steffen, B. T. et al. Obesity modifies the association between plasma phospholipid polyunsaturated fatty acids and markers of inflammation: the multi-ethnic study of atherosclerosis. Int. J. Obes. (Lond.) 36, 797\u2013804. https:\/\/doi.org\/10.1038\/ijo.2011.157 (2012).","journal-title":"Int. J. Obes. (Lond.)"},{"key":"72852_CR39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.diabres.2015.05.032","volume":"109","author":"O Uhl","year":"2015","unstructured":"Uhl, O. et al. Effects of obesity and gestational diabetes mellitus on placental phospholipids. Diabetes Res. Clin. Pract. 109, 364\u2013371. https:\/\/doi.org\/10.1016\/j.diabres.2015.05.032 (2015).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"72852_CR40","doi-asserted-by":"publisher","first-page":"W94","DOI":"10.1093\/nar\/gku436","volume":"42","author":"F Allen","year":"2014","unstructured":"Allen, F., Pon, A., Wilson, M., Greiner, R. & Wishart, D. CFM-ID: a web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra. Nucleic Acids Res. 42, W94\u2013W99 (2014).","journal-title":"Nucleic Acids Res."},{"key":"72852_CR41","doi-asserted-by":"crossref","unstructured":"41Shao, M. et al. Serum and urine metabolomics reveal potential biomarkers of T2DM patients with nephropathy. Ann. Transl. Med.8 (2020).","DOI":"10.21037\/atm.2020.01.42"},{"key":"72852_CR42","doi-asserted-by":"crossref","unstructured":"42Ortiz, S. R. & Field, M. S. Mammalian metabolism of erythritol: a predictive biomarker of metabolic dysfunction. Curr. Opin. Clin. Nutrit. Metab. Care (2020).","DOI":"10.1097\/MCO.0000000000000665"},{"key":"72852_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.foodres.2019.02.021","volume":"120","author":"EM Lee","year":"2019","unstructured":"Lee, E. M. et al. Highly geographical specificity of metabolomic traits among Korean domestic soybeans (Glycine max). Food Res. Int. 120, 12\u201318 (2019).","journal-title":"Food Res. Int."},{"key":"72852_CR44","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/15548627.2015.1034414","volume":"11","author":"M Melland-Smith","year":"2015","unstructured":"Melland-Smith, M. et al. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia. Autophagy 11, 653\u2013669. https:\/\/doi.org\/10.1080\/15548627.2015.1034414 (2015).","journal-title":"Autophagy"},{"key":"72852_CR45","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.clinbiochem.2009.07.011","volume":"42","author":"L Romanowicz","year":"2009","unstructured":"Romanowicz, L. & Bankowski, E. Preeclampsia-associated alterations in sphingolipid composition of the umbilical cord artery. Clin. Biochem. 42, 1719\u20131724. https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.07.011 (2009).","journal-title":"Clin. Biochem."},{"key":"72852_CR46","doi-asserted-by":"publisher","first-page":"e0177601","DOI":"10.1371\/journal.pone.0177601","volume":"12","author":"K Charkiewicz","year":"2017","unstructured":"Charkiewicz, K. et al. Sphingolipids as a new factor in the pathomechanism of preeclampsia - mass spectrometry analysis. PLoS ONE 12, e0177601. https:\/\/doi.org\/10.1371\/journal.pone.0177601 (2017).","journal-title":"PLoS ONE"},{"key":"72852_CR47","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","volume":"369","author":"LM Askie","year":"2007","unstructured":"Askie, L. M., Duley, L., Henderson-Smart, D. J., Stewart, L. A. & Group, P. C. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369, 1791\u20131798. https:\/\/doi.org\/10.1016\/S0140-6736(07)60712-0 (2007).","journal-title":"Lancet"},{"key":"72852_CR48","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7326\/M13-2844","volume":"160","author":"JT Henderson","year":"2014","unstructured":"Henderson, J. T. et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the US Preventive Services Task Force. Ann. Intern. Med. 160, 695\u2013703. https:\/\/doi.org\/10.7326\/M13-2844 (2014).","journal-title":"Ann. Intern. Med."},{"key":"72852_CR49","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","volume":"132","author":"ACOG Committee Opinion No. 743","year":"2018","unstructured":"ACOG Committee Opinion No. 743. Low-dose aspirin use during pregnancy. Obstet Gynecol 132, e44\u2013e52. https:\/\/doi.org\/10.1097\/AOG.0000000000002708 (2018).","journal-title":"Obstet Gynecol"},{"key":"72852_CR50","doi-asserted-by":"publisher","unstructured":"50LeFevre, M. L. & Force, U. S. P. S. T. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med.161, 819\u2013826, https:\/\/doi.org\/10.7326\/M14-1884 (2014).","DOI":"10.7326\/M14-1884"},{"key":"72852_CR51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajog.2016.09.086","volume":"216","author":"F Mone","year":"2017","unstructured":"Mone, F., Mulcahy, C., McParland, P. & McAuliffe, F. M. Should we recommend universal aspirin for all pregnant women?. Am. J. Obstet. Gynecol. 216, 141\u2013145. https:\/\/doi.org\/10.1016\/j.ajog.2016.09.086 (2017).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"72852_CR52","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik, D. L. et al. Aspirin versus Placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 377, 613\u2013622. https:\/\/doi.org\/10.1056\/NEJMoa1704559 (2017).","journal-title":"N. Engl. J. Med."},{"key":"72852_CR53","doi-asserted-by":"publisher","first-page":"12172","DOI":"10.1038\/s41598-017-12491-4","volume":"7","author":"L Ermini","year":"2017","unstructured":"Ermini, L. et al. A Single sphingomyelin species promotes exosomal release of endoglin into the maternal circulation in preeclampsia. Sci. Rep. 7, 12172. https:\/\/doi.org\/10.1038\/s41598-017-12491-4 (2017).","journal-title":"Sci. Rep."},{"key":"72852_CR54","doi-asserted-by":"publisher","unstructured":"54Publications Committee, S. f. M.-F. M. & Sibai, B. M. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am. J. Obstet. Gynecol.205, 191\u2013198, https:\/\/doi.org\/10.1016\/j.ajog.2011.07.017 (2011).","DOI":"10.1016\/j.ajog.2011.07.017"},{"key":"72852_CR55","first-page":"109","volume":"8","author":"DY Ji","year":"2017","unstructured":"Ji, D. Y., Lee, C.-W., Park, S. H., Lee, E. J. & Lee, D. Y. Simple and robust measurement of blood plasma lysophospholipids using liquid chromatography mass spectrometry. Mass Spectrom. Lett. 8, 109\u2013113 (2017).","journal-title":"Mass Spectrom. Lett."},{"key":"72852_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17765-5","volume":"8","author":"DY Ji","year":"2018","unstructured":"Ji, D. Y. et al. Comparative assessment of Graves\u2019 disease and main extrathyroidal manifestation, Graves\u2019 ophthalmopathy, by non-targeted metabolite profiling of blood and orbital tissue. Sci. Rep. 8, 1\u201311 (2018).","journal-title":"Sci. Rep."},{"key":"72852_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"SJ Park","year":"2019","unstructured":"Park, S. J. et al. Integrative metabolomics reveals unique metabolic traits in Guillain-Barr\u00e9 Syndrome and its variants. Sci. Rep. 9, 1\u201314 (2019).","journal-title":"Sci. Rep."},{"key":"72852_CR58","doi-asserted-by":"publisher","first-page":"e116221","DOI":"10.1371\/journal.pone.0116221","volume":"9","author":"AR Dalby","year":"2014","unstructured":"Dalby, A. R. et al. Metabolomics data normalization with EigenMS. PLoS ONE 9, e116221. https:\/\/doi.org\/10.1371\/journal.pone.0116221 (2014).","journal-title":"PLoS ONE"},{"key":"72852_CR59","doi-asserted-by":"publisher","first-page":"W162","DOI":"10.1093\/nar\/gkx449","volume":"45","author":"B Li","year":"2017","unstructured":"Li, B. et al. NOREVA: normalization and evaluation of MS-based metabolomics data. Nucleic Acids Res. 45, W162\u2013W170. https:\/\/doi.org\/10.1093\/nar\/gkx449 (2017).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72852-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72852-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72852-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:22:32Z","timestamp":1670358152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72852-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72852"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72852-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"31 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16142"}}